Which pharmacokinetic parameter best distinguishes a drug with high hepatic first-pass metabolism from one with low first-pass metabolism?

Explanation

## Distinguishing First-Pass Metabolism: Bioavailability Comparison ### Definition of First-Pass Metabolism First-pass (presystemic) metabolism occurs when an orally administered drug is metabolized by hepatic and/or intestinal enzymes before reaching systemic circulation. This reduces the amount of unchanged drug reaching the systemic circulation. ### Key Pharmacokinetic Relationship **Key Point:** Bioavailability (F) is the fraction of administered dose that reaches systemic circulation unchanged. For drugs undergoing significant first-pass metabolism, oral bioavailability is markedly lower than intravenous bioavailability. $$F_{oral} = \frac{AUC_{oral}}{AUC_{IV}} \times \frac{Dose_{IV}}{Dose_{oral}}$$ When first-pass metabolism is high: - F (oral) << F (IV, which = 1.0) - This creates a **large discrepancy** between oral and IV bioavailability ### Comparison Table: High vs. Low First-Pass Metabolism | Feature | High First-Pass | Low First-Pass | | --- | --- | --- | | **Oral bioavailability** | <30% (often <10%) | >70% | | **IV bioavailability** | 100% | 100% | | **Bioavailability ratio (F_oral/F_IV)** | Markedly reduced | Similar | | **Clinical example** | Nitroglycerin, propranolol, morphine | Acetaminophen, aspirin | | **Route preference** | Sublingual, transdermal, IV preferred | Oral route effective | **High-Yield:** The **absolute difference** between oral and IV bioavailability is the gold-standard discriminator. A drug with F_oral = 10% and F_IV = 100% clearly has high first-pass metabolism; one with F_oral = 80% and F_IV = 100% does not. ### Clinical Pearl Nitroglycerin (oral bioavailability ~10%) is given sublingually (bypasses first-pass) to achieve therapeutic levels; the same dose orally would be ineffective. Propranolol (F_oral ~25%) requires higher oral doses than IV doses to achieve equivalent effects. ### Why This Parameter Matters - **Dose adjustment:** Oral doses must be higher than IV doses for high first-pass drugs - **Route selection:** Sublingual, transdermal, rectal, or IV routes preferred - **Drug interactions:** Hepatic enzyme inhibitors (e.g., cimetidine) increase oral bioavailability by reducing first-pass metabolism